跳至主要内容
临床试验/NCT06805942
NCT06805942招募中不适用

Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis

IR Centers1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年2月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10
试验地点
1
主要终点
Reduction in Pain (VAS Score)

研究概览

简要总结

This study evaluates the feasibility and safety of using Lipiodol (ethiodized oil) as an investigational embolic agent for treating pain caused by plantar fasciitis. Participants will undergo a minimally invasive procedure called plantar fascia embolization (PFE) to reduce inflammation and pain in the affected area. The study aims to assess changes in pain levels, foot function, and any potential side effects over a six-month follow-up period.

详细描述

This study investigates the use of Lipiodol (ethiodized oil) for plantar fascia embolization (PFE) to treat pain from plantar fasciitis. It focuses on evaluating safety, feasibility, and outcomes related to pain reduction and improved foot function.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants aged 22 years or older. Diagnosed with plantar fasciitis by an orthopedic or podiatry surgeon.
  • •Ultrasound evaluation showing:
  • •Increased plantar fascia thickness > 4 mm. Hyperemia in the plantar fascia near its proximal insertion or perifascial soft tissue.
  • •Self-reported pain of at least 5/10 on the Visual Analog Scale (VAS). Negative X-ray for acute fractures. Refractory to at least 6 weeks of conservative therapies. Able to provide written informed consent. -

排除标准

  • •Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis.
  • •Corticosteroid injection in the plantar fascia within 90 days prior to embolization.
  • •Prior surgical repair or plantar fascia rupture. Severe allergy to Lipiodol or iodinated contrast media. Diagnosis of peripheral arterial disease affecting the lower extremities. Active workers' compensation claim for plantar fasciitis. Pregnancy or breastfeeding. Type 1 Diabetes Mellitus or significant renal dysfunction (GFR < 45 or serum creatinine > 2.0 mg/dL).
  • •Sensory or motor neuropathy of the feet. Active skin wounds on the plantar surface of the affected foot.

研究组 & 干预措施

Single Intervention Group

Experimental

Participants in this arm will receive plantar fascia embolization (PFE) using Lipiodol (ethiodized oil) to treat pain caused by plantar fasciitis.

干预措施: Lipiodol (ethiodized oil) injection (Device)

结局指标

主要结局

Reduction in Pain (VAS Score)

时间窗: Baseline to 6 months

Change in pain level as measured by the Visual Analog Scale (VAS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable).

次要结局

  • Improvement in Foot Function (FAAM Score)(Baseline to 6 months)

研究者

发起方
IR Centers
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验